Skip to main content
BMC Cancer logoLink to BMC Cancer
. 2018 Apr 12;18:413. doi: 10.1186/s12885-018-4200-5

Correction to: Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy

Kim A Brogden 1,✉, Deepak Parashar 2, Andrea R Hallier 3, Terry Braun 3, Fang Qian 1,4, Naiyer A Rizvi 5, Aaron D Bossler 6, Mohammed M Milhem 7, Timothy A Chan 8, Taher Abbasi 9, Shireen Vali 9
PMCID: PMC5898039  PMID: 29649990

Correction

It has been highlighted that in the original manuscript [1] Table S3 ‘An example of the predictive computational modeling process. Specific details on an annexure section of the PD-L1 pathway show the step-by-step reactions, mechanisms, and reaction equations that occur. Such reactions also occurred in all of the other pathways’ was omitted and did not appear in the Additional files. The original article has been updated.

Footnotes

The original article can be found online at 10.1186/s12885-018-4134-y

Reference

  • 1.Brogden KA, et al. Genomics of NSCLC patients both affirm PD-L1 expression and predict their clinical responses to anti-PD-1 immunotherapy. BMC Cancer. 2018;18:225. doi: 10.1186/s12885-018-4134-y. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMC Cancer are provided here courtesy of BMC

RESOURCES